Skip to main content
. 2012 Jan 12;7:235–242. doi: 10.2147/IJN.S27722

Figure 8.

Figure 8

Schematic illustration of the possible process of distinct improvement in anticancer activity by the novel pH-responsive drug delivery system based on titanium dioxide nanoparticles for daunorubicin.

Abbreviations: DNR, daunorubicin; Nps, nanoparticles; DNR-TiO2, daunorubicin-titanium dioxide nanocomposites; TiO2, titanium dioxide.